^
Droplex BRAF Mutation Test is a qualitative test for mutations in BRAF gene Codon 600 in DNA derived from tissue from paraffin-embedded (FFPET) melanoma and PTC patients after formalin fixation using the droplet digital polymerase chain reaction method. Used to help select patients with BRAF Codon 600 mutations for Zelboraf (Vemurafenib) in melanoma patients.
Cancer:
Colorectal Cancer, Melanoma, Thyroid Gland Papillary Carcinoma
Gene:
BRAF (B-raf proto-oncogene)
Drug:
Zelboraf (vemurafenib)
Method:
PCR
Approvals
Date
Cancer
Gene
Drug
By
04/21/22
CE